2Zheng Y, Schachern PA, Sone M , et al. Aminoglycoside ototoxicity [J]. Otol Neurotol,2001,22(2) : 266.
3Wu WJ, Sha SH, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention [J]. Audiol Neurootol, 2002,7 (3) : 171.
4I Tange RA. Eardrops and aminoglycoside ototoxicity revisited[J]. Aclverse Drug React Toaxicol Rev , 2001,20(3) :164.
5Fisman DN, Kaye KM . Once- daily dosing of aminoglycoside antibiotics [J]. Infect Dis Clin North Am, 2000,14(2) :475.
6Beringer PM, Vinks AA, Jelliffe RW, et al. Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once- daily administration [J] . Antimicrob Agents Chemother, 2000,44(4) : 809.
7I De Sarro A, De - Sarro G. Adverse reactions to fluoroquinolones, an overview on mechanistic aspects [J]. Curt Med Chem ,2001,8(4) :371.
8Mandell L A, Ball P,Tillotson G. Amtimicrobial safety and tolerability: differences and dilemmas [J]. Clin Infect Dis ,2001,32( Suppl 1): S72.
9Rubinstein E. History of quinolones and their side effects [J]. Chemotherapy ,2001,47(Suppl 3) :3.
10YANG Y, LI Q, MIYASHITA H, et al. Usefuless of post-ischemic thrombolysis with or without neuroprotection in a focal embolic model of cerebral ischemia [J]. J Neruosurg,2000,92 (5): 841-847.
